Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02472275
Title PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

prostate adenocarcinoma

Therapies

Leuprolide

Pexidartinib

Goserelin

Degarelix

Age Groups: adult
Covered Countries USA


No variant requirements are available.